• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在凝血酶和纤维蛋白生成同步检测中,对凝块形成时凝血酶浓度的研究。

Investigation of thrombin concentration at the time of clot formation in simultaneous thrombin and fibrin generation assays.

作者信息

Tarandovskiy Ivan D, Surov Stepan S, Parunov Leonid A, Liang Yideng, Jankowski Wojciech, Sauna Zuben E, Ovanesov Mikhail V

机构信息

U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.

出版信息

Sci Rep. 2024 Apr 22;14(1):9225. doi: 10.1038/s41598-023-47694-5.

DOI:10.1038/s41598-023-47694-5
PMID:38649717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11035586/
Abstract

Thrombin generation (TG) and fibrin clot formation represent the central process of blood coagulation. Up to 95% of thrombin is considered to be generated after the clot is formed. However, this was not investigated in depth. In this study, we conducted a quantitative analysis of the Thrombin at Clot Time (TCT) parameter in 5758 simultaneously recorded TG and clot formation assays using frozen plasma samples from commercial sources under various conditions of activation. These samples were supplemented with clotting factor concentrates, procoagulant lipid vesicles and a fluorogenic substrate and triggered with tissue factor (TF). We found that TCT is often close to a 10% of thrombin peak height (TPH) yet it can be larger or smaller depending on whether the sample has low or high TPH value. In general, the samples with high TPH are associated with elevated TCT. TCT appeared more sensitive to some procoagulant phenotypes than other commonly used parameters such as clotting time, TPH or Thrombin Production Rate (TPR). In a minority of cases, TCT were not predicted from TG parameters. For example, elevated TCT (above 15% of TPH) was associated with either very low or very high TPR values. We conclude that clotting and TG assays may provide complementary information about the plasma sample, and that the TCT parameter may serve as an additional marker for the procoagulant potential in plasma sample.

摘要

凝血酶生成(TG)和纤维蛋白凝块形成是血液凝固的核心过程。高达95%的凝血酶被认为是在凝块形成后产生的。然而,这一点并未得到深入研究。在本研究中,我们使用来自商业来源的冷冻血浆样本,在各种激活条件下,对5758次同时记录的TG和凝块形成试验中的凝血酶凝块时间(TCT)参数进行了定量分析。这些样本补充了凝血因子浓缩物、促凝脂质囊泡和一种荧光底物,并用组织因子(TF)触发。我们发现,TCT通常接近凝血酶峰值高度(TPH)的10%,但它可能更大或更小,这取决于样本的TPH值是低还是高。一般来说,TPH高的样本与TCT升高有关。与凝血时间、TPH或凝血酶产生率(TPR)等其他常用参数相比,TCT对某些促凝表型似乎更敏感。在少数情况下,TCT无法从TG参数预测。例如,TCT升高(高于TPH的15%)与非常低或非常高的TPR值有关。我们得出结论,凝血和TG试验可能提供有关血浆样本的补充信息,并且TCT参数可能作为血浆样本促凝潜力的一个额外标志物。

相似文献

1
Investigation of thrombin concentration at the time of clot formation in simultaneous thrombin and fibrin generation assays.在凝血酶和纤维蛋白生成同步检测中,对凝块形成时凝血酶浓度的研究。
Sci Rep. 2024 Apr 22;14(1):9225. doi: 10.1038/s41598-023-47694-5.
2
Interconnectedness of global hemostasis assay parameters in simultaneously evaluated thrombin generation, fibrin generation and clot lysis in normal plasma.正常血浆中同时评估凝血酶生成、纤维蛋白生成和凝块溶解时全球止血测定参数的相互关联性。
Thromb Res. 2016 Apr;140:132-139. doi: 10.1016/j.thromres.2015.11.023. Epub 2015 Nov 19.
3
Determination of fibrin clot growth and spatial thrombin propagation in the presence of different types of phospholipid surfaces.测定不同类型磷脂表面存在下纤维蛋白凝块的生长和空间凝血酶的传播。
Platelets. 2021 Nov 17;32(8):1031-1037. doi: 10.1080/09537104.2020.1823360. Epub 2020 Sep 23.
4
Comparative Thrombin Generation in Animal Plasma: Sensitivity to Human Factor XIa and Tissue Factor.动物血浆中凝血酶生成的比较:对人因子 XIa 和组织因子的敏感性。
Int J Mol Sci. 2023 Aug 18;24(16):12920. doi: 10.3390/ijms241612920.
5
Sensitivity and Robustness of Spatially Dependent Thrombin Generation and Fibrin Clot Propagation.空间相关凝血酶生成和纤维蛋白凝块传播的灵敏度和稳健性。
Biophys J. 2018 Dec 18;115(12):2461-2473. doi: 10.1016/j.bpj.2018.11.009. Epub 2018 Nov 14.
6
Effects of an acidic environment on coagulation dynamics.酸性环境对凝血动力学的影响。
J Thromb Haemost. 2016 Oct;14(10):2001-2010. doi: 10.1111/jth.13418. Epub 2016 Sep 12.
7
Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.血浆中凝血酶对因子XI的反馈激活导致额外的凝血酶生成,从而保护纤维蛋白凝块免受纤维蛋白溶解。
Blood. 1995 Oct 15;86(8):3035-42.
8
The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.使用荧光底物测量凝血酶生成的技术:3. 样品稀释的影响。
Thromb Haemost. 2009 Jan;101(1):165-70.
9
Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow.建立血栓的瞬态质量平衡:从组织因子到凝血酶到静脉血流下的纤维蛋白。
Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1528-1536. doi: 10.1161/ATVBAHA.118.310906. Epub 2018 May 3.
10
The effect of factor XIa on thrombin and plasmin generation, clot formation, lysis and density in coagulation factors deficiencies.FXIa 对凝血因子缺乏症中凝血酶和纤溶酶生成、血栓形成、溶解和密度的影响。
Thromb Res. 2024 Jan;233:189-199. doi: 10.1016/j.thromres.2023.11.024. Epub 2023 Nov 23.

引用本文的文献

1
Effects of coagulation factors on bone cells and consequences of their absence in haemophilia a patients.凝血因子对骨细胞的影响及其在血友病 A 患者中缺失的后果。
Sci Rep. 2024 Oct 23;14(1):25001. doi: 10.1038/s41598-024-75747-w.

本文引用的文献

1
COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity.COVID-19 和脓毒症与血浆促凝和纤溶活性的不同异常有关。
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):401-414. doi: 10.1161/ATVBAHA.120.315338. Epub 2020 Nov 16.
2
A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice.高脂肪饮食以血栓调节蛋白依赖的方式延缓纤溶酶原的生成在小鼠中。
Blood. 2020 May 7;135(19):1704-1717. doi: 10.1182/blood.2019004267.
3
Interspecies comparison of simultaneous thrombin and plasmin generation.
种间比较的同时凝血酶和纤溶酶的产生。
Sci Rep. 2020 Mar 3;10(1):3885. doi: 10.1038/s41598-020-60436-1.
4
Comparison between thromboelastography and thromboelastometry.血栓弹力描记术与血栓弹力测定术的比较。
Minerva Anestesiol. 2019 Dec;85(12):1346-1356. doi: 10.23736/S0375-9393.19.13687-5. Epub 2019 Oct 14.
5
Mitigation of T-cell dependent immunogenicity by reengineering factor VIIa analogue.通过改造因子 VIIa 类似物来减轻 T 细胞依赖性免疫原性。
Blood Adv. 2019 Sep 10;3(17):2668-2678. doi: 10.1182/bloodadvances.2019000338.
6
The central role of thrombin in bleeding disorders.凝血酶在出血性疾病中的核心作用。
Blood Rev. 2019 Nov;38:100582. doi: 10.1016/j.blre.2019.05.006. Epub 2019 May 22.
7
Contradictory to its effects on thrombin, C1-inhibitor reduces plasmin generation in the presence of thrombomodulin.与它对凝血酶的作用相反,C1 抑制剂在血栓调节蛋白存在的情况下减少纤溶酶的生成。
J Thromb Thrombolysis. 2019 Jul;48(1):81-87. doi: 10.1007/s11239-019-01869-y.
8
A review of commercially available thrombin generation assays.市售凝血酶生成检测方法综述。
Res Pract Thromb Haemost. 2017 Oct 16;2(1):42-48. doi: 10.1002/rth2.12048. eCollection 2018 Jan.
9
Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency.部分因子 XI 缺乏症患者的血浆异常凝结形成和纤维蛋白溶解揭示了出血倾向。
Blood Adv. 2018 May 22;2(10):1076-1088. doi: 10.1182/bloodadvances.2017015123.
10
Haemophilia B: Where are we now and what does the future hold?血友病 B:我们现在在哪里,未来会怎样?
Blood Rev. 2018 Jan;32(1):52-60. doi: 10.1016/j.blre.2017.08.007. Epub 2017 Aug 16.